Last checked at 25 Jun 2021 12:37
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | AON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 24 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
570,333 | 0.25% | 1,740,360 | 0.77% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
288,605 | 0.13% | 0 | 0.00% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 24,200 | 0.01% | 24,200 | 0.01% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
883,138 | 0.39% | 1,764,560 | 0.78% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 8 | 238.4650 USD |
| Purchase | 18 | 238.1527 USD |
| Purchase | 25 | 237.6488 USD |
| Purchase | 41 | 237.9753 USD |
| Purchase | 46 | 238.0021 USD |
| Purchase | 69 | 238.0804 USD |
| Purchase | 77 | 238.3629 USD |
| Purchase | 80 | 237.9937 USD |
| Purchase | 114 | 238.6682 USD |
| Purchase | 118 | 235.5000 USD |
| Purchase | 160 | 238.4237 USD |
| Purchase | 187 | 237.7100 USD |
| Purchase | 196 | 237.1515 USD |
| Purchase | 212 | 238.3691 USD |
| Purchase | 230 | 238.1884 USD |
| Purchase | 298 | 237.9900 USD |
| Purchase | 300 | 237.9600 USD |
| Purchase | 301 | 237.9663 USD |
| Purchase | 301 | 238.4627 USD |
| Purchase | 310 | 236.7048 USD |
| Purchase | 326 | 238.8165 USD |
| Purchase | 331 | 238.1505 USD |
| Purchase | 383 | 238.8712 USD |
| Purchase | 386 | 237.4583 USD |
| Purchase | 430 | 238.3973 USD |
| Purchase | 599 | 237.9933 USD |
| Purchase | 612 | 238.1427 USD |
| Purchase | 700 | 238.3026 USD |
| Purchase | 762 | 238.0000 USD |
| Purchase | 803 | 238.5080 USD |
| Purchase | 864 | 238.3592 USD |
| Purchase | 1,010 | 237.9998 USD |
| Purchase | 1,020 | 238.3574 USD |
| Purchase | 1,145 | 238.4055 USD |
| Purchase | 1,214 | 238.5343 USD |
| Purchase | 1,306 | 238.4001 USD |
| Purchase | 1,313 | 238.4416 USD |
| Purchase | 1,401 | 237.9400 USD |
| Purchase | 1,560 | 237.9613 USD |
| Purchase | 1,978 | 238.1874 USD |
| Purchase | 2,296 | 238.3996 USD |
| Purchase | 2,435 | 238.2460 USD |
| Purchase | 3,630 | 235.5668 USD |
| Purchase | 4,080 | 237.8343 USD |
| Purchase | 4,550 | 238.4800 USD |
| Purchase | 4,692 | 238.2702 USD |
| Purchase | 7,487 | 238.3109 USD |
| Purchase | 9,678 | 237.9554 USD |
| Purchase | 10,800 | 236.8534 USD |
| Purchase | 12,627 | 238.3615 USD |
| Purchase | 13,817 | 238.0560 USD |
| Purchase | 17,392 | 238.3238 USD |
| Purchase | 66,605 | 238.1376 USD |
| Purchase | 130,326 | 238.4788 USD |
| Sale | 1 | 238.4500 USD |
| Sale | 1 | 238.3800 USD |
| Sale | 2 | 236.7150 USD |
| Sale | 5 | 235.9600 USD |
| Sale | 5 | 238.6750 USD |
| Sale | 5 | 238.6500 USD |
| Sale | 5 | 238.6400 USD |
| Sale | 5 | 238.6000 USD |
| Sale | 5 | 238.5700 USD |
| Sale | 5 | 238.4700 USD |
| Sale | 5 | 238.4200 USD |
| Sale | 10 | 238.6900 USD |
| Sale | 19 | 238.4400 USD |
| Sale | 30 | 236.0600 USD |
| Sale | 33 | 237.1600 USD |
| Sale | 38 | 238.5231 USD |
| Sale | 41 | 237.9753 USD |
| Sale | 68 | 236.8705 USD |
| Sale | 77 | 236.7400 USD |
| Sale | 86 | 235.5300 USD |
| Sale | 100 | 238.7300 USD |
| Sale | 102 | 237.2339 USD |
| Sale | 102 | 237.1947 USD |
| Sale | 110 | 237.1998 USD |
| Sale | 134 | 236.7774 USD |
| Sale | 160 | 237.5198 USD |
| Sale | 162 | 238.1669 USD |
| Sale | 179 | 235.6855 USD |
| Sale | 193 | 237.4583 USD |
| Sale | 199 | 235.7178 USD |
| Sale | 200 | 237.0200 USD |
| Sale | 200 | 238.6700 USD |
| Sale | 254 | 235.8862 USD |
| Sale | 254 | 235.5000 USD |
| Sale | 328 | 237.9308 USD |
| Sale | 384 | 238.1246 USD |
| Sale | 400 | 238.1580 USD |
| Sale | 500 | 238.3610 USD |
| Sale | 515 | 235.6522 USD |
| Sale | 774 | 235.4866 USD |
| Sale | 945 | 236.6657 USD |
| Sale | 1,341 | 238.3916 USD |
| Sale | 1,356 | 236.8002 USD |
| Sale | 1,362 | 237.0077 USD |
| Sale | 1,445 | 236.8947 USD |
| Sale | 1,492 | 237.9600 USD |
| Sale | 1,592 | 236.8009 USD |
| Sale | 1,618 | 235.4968 USD |
| Sale | 2,173 | 236.6941 USD |
| Sale | 3,410 | 237.8899 USD |
| Sale | 3,606 | 238.1972 USD |
| Sale | 3,773 | 236.8986 USD |
| Sale | 4,154 | 238.1885 USD |
| Sale | 4,465 | 238.1486 USD |
| Sale | 5,000 | 237.9673 USD |
| Sale | 6,095 | 237.9198 USD |
| Sale | 8,450 | 237.9227 USD |
| Sale | 10,310 | 238.3586 USD |
| Sale | 13,766 | 238.2213 USD |
| Sale | 13,827 | 238.4685 USD |
| Sale | 22,909 | 238.3889 USD |
| Sale | 28,723 | 238.3257 USD |
| Sale | 42,910 | 238.1325 USD |
| Sale | 121,081 | 238.4800 USD |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
|
| unit | |
| SWAP | Long | 116,453 | 238.4800 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 25 Jun 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price |
| date | |
| to which the option |
|
|
| |
| or derivative |
|
|
| |
| relates |
|
|
| |
| Put Options | Purchased | -1,200 | 220.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 1,200 | 240.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 23,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -23,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210625005225/en/
Copyright Business Wire 2021